Estimations of the Increasing Prevalence and Plateau Prevalence of Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors Therapy

類似資料

• Tyrosine kinase inhibitor–induced platelet dysfunction in patients with chronic myeloid leukemia
  著者:: Quintás-Cardama, Alfonso, 等
  出版事項: (2009)
• Considerations in the Management of Patients With Philadelphia Chromosome–Positive Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor Therapy
  著者:: Kantarjian, Hagop, 等
  出版事項: (2011)
• Molecular Monitoring in Chronic Myeloid Leukemia: Response to Tyrosine Kinase Inhibitors and Prognostic Implications
  著者:: Jabbour, Elias, 等
  出版事項: (2008)
• PREDICTING OUTCOMES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA AT ANY TIME DURING TYROSINE KINASE INHIBITOR THERAPY
  著者:: Quintás-Cardama, Alfonso, 等
  出版事項: (2014)
• Front-Line and Salvage Therapies With Tyrosine Kinase Inhibitors and Other Treatments in Chronic Myeloid Leukemia
  著者:: Cortes, Jorge, 等
  出版事項: (2011)